Recent Finacing
Recent Raise
Sangart develops investigational biopharmaceuticals to enhance perfusion and deliver therapeutic gases, advancing MP4OX for capillary oxygen delivery in traumatic hemorrhage and MP4CO for sickle cell crises.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor